Interventional study for correlation analysis on food intake and glucose levels with continuous glucose monitoring (CGM) system in glycogen storage disease type Ia

Interventional study for correlation analysis on food intake and glucose levels with continuous glucose monitoring (CGM) system in glycogen storage disease type Ia - CGM study in glycogen storage disease type Ia

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000042026

Enrollment

Registered

2020-10-06

Start date

2020-10-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

glycogen storage disease type Ia

Interventions

Measure interstitial fluid glucose levels using CGM for 14 days

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Patients who have written informed consent by themselves or the legal representative 2. Patients who are 2 years or older 3. Patients diagnosed Glycogen storage disease type Ia by Genetic testing

Exclusion criteria

Exclusion criteria: 1. Patients who are implanted pace maker 2. Patients after living donor liver transplantation 3. Females who are in pregnancy, breastfeeding 4. Patients whose participation in the trial was judged to be inappropriate by the investigator

Design outcomes

Primary

Measure	Time frame
Number of times interstitial fluid glucose levels is 4.0 mmol/ L or less during use of CGM per patient	—

Countries

Japan

Contacts

Public ContactYosuke Wasaki

DAIICHI SANKYO CO., LTD Clinical Development 3

wasaki.yosuke.hi@daiichisankyo.co.jp03-3492-3131

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026